{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:16:20Z","timestamp":1792163780885,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1124\/dmd.110.036715","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T03:44:54Z","timestamp":1293075894000},"page":"580-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Metabolism and Excretion of Asenapine in Healthy Male Subjects"],"prefix":"10.1016","volume":"39","author":[{"given":"SFM","family":"van de Wetering-Krebbers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PL","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GJ","family":"Kemperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Spaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAM","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LPC","family":"Delbressine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MLPS","family":"van Iersel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.036715_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0090-9556(25)08555-1","article-title":"Isolation and characterization of an unusual glucuronide conjugate of rimantadine","volume":"18","author":"Brown","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036715_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00498259009046820","article-title":"On the formation of carbamate glucuronides","volume":"20","author":"Delbressine","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.036715_bib3","first-page":"S86","article-title":"A phase I study to investigate the safety, tolerability, and pharmacokinetics of single and multiple doses of sublingually administered asenapine in healthy male volunteers","volume":"85","author":"Dogterom","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.036715_bib4","first-page":"830","article-title":"N+-Glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group","volume":"26","author":"Hawes","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036715_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/JCP.0b013e3181d35d6b","article-title":"Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia","volume":"30","author":"Kane","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.110.036715_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1124\/dmd.110.036715_bib7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1399-5618.2009.00749.x","article-title":"Asenapine versus olanzapine in acute mania: a double-blind extension study","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1124\/dmd.110.036715_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1124\/dmd.110.036715_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/dmd.104.002428","article-title":"Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study","volume":"33","author":"Obach","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036715_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/dmd.105.006767","article-title":"Metabolism and disposition of varenicline, a selective \u03b14\u03b22 acetylcholine receptor partial agonist, in vivo and in vitro","volume":"34","author":"Obach","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036715_bib11","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4088\/JCP.v68n1004","article-title":"Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial","volume":"68","author":"Potkin","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/dmd.110.036715_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/clpt.1982.49","article-title":"On the kinetics and dynamics of tocainide and its metabolites","volume":"31","author":"Ronfeld","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.036715_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/138920006779010629","article-title":"Reaction of primary and secondary amines to form carbamic acid glucuronides","volume":"7","author":"Schaefer","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.110.036715_bib14","series-title":"Saphris (asenapine) sublingual tablets. Full prescribing information","year":"2010"},{"key":"10.1124\/dmd.110.036715_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0030-1248313","article-title":"Long-term assessment of asenapine vs. olanzapine in patients with schizophrenia or schizoaffective disorder","volume":"43","author":"Schoemaker","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/dmd.110.036715_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1124\/dmd.110.036715_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0090-9556(25)06946-6","article-title":"Benzazepine metabolism revisited. Evidence for the formation of novel amine conjugates","volume":"16","author":"Straub","year":"1988","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036715_bib18","first-page":"540","article-title":"Biotransformation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1-H-dibenz[2,3:6,7]-oxepino[4,5-c]pyrrolidine maleate in rats","volume":"40","author":"von dem Wildenberg","year":"1990","journal-title":"Arzneimittelforschung"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.036715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:40:14Z","timestamp":1739904014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624057283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0090955624057283"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.036715","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism and Excretion of Asenapine in Healthy Male Subjects","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.036715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}